Expression of vascular endothelial growth factor family members in head and neck squamous cell carcinoma correlates with lymph node metastasis

Cancer

Volumn 92, Issue 3, 2001, Pages 556-568

  O charoenrat, Pornchai ^a,b   Rhys Evans, Peter ^a,b   Eccles, Suzanne A ^a,b  

^a ROYAL MARSDEN HOSPITAL   (United Kingdom)

^b INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

Angiogenesis; Head and neck cancer; Invasion; Lymph node metastasis; Multivariate analysis; Squamous cell carcinoma; Vascular endothelial growth factor

Indexed keywords

VASCULOTROPIN;

ADULT; ARTICLE; CANCER INVASION; CELL CULTURE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBROBLAST; HEAD AND NECK CARCINOMA; HUMAN; HUMAN TISSUE; KERATINOCYTE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; WESTERN BLOTTING;

CARCINOMA, SQUAMOUS CELL; ENDOTHELIAL GROWTH FACTORS; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; LOGISTIC MODELS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL; UTERINE CERVICAL NEOPLASMS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR B; VASCULAR ENDOTHELIAL GROWTH FACTOR C; VASCULAR ENDOTHELIAL GROWTH FACTOR D;

EID: 0035423906     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0142(20010801)92:3<556::AID-CNCR1355>3.0.CO;2-Q     Document Type: Article

References (54)

1. Forty years of monitoring head and neck cancer in Norway - No good news
2. Nodal metastases: Predictive factors
3. Regulation of angiogenesis via vascular endothelial growth factor receptors
4. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid
5. Isolation of a human placenta cDNA coding for a protein related to the vascular permeability factor
6. Vascular endothelial growth factor B, a novel growth factor for endothelial cells
7. A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases
8. Vascular endothelial growth factor-related protein: A ligand and specific activator of the tyrosine kinase receptor Flt4
9. Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4)
10. A novel vascular endothelial growth factor encoded by Orf virus, VEGF-E, mediates angiogenesis via signalling through VEGFR-2 (KDR) but not VEGFR-1 (Flt-1) receptor tyrosine kinases
11. The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing
12. VEGF121, a vascular endothelial growth factor (VEGF) isoform lacking heparin binding ability, requires cell-surface heparan sulfates for efficient binding to the VEGF receptors of human melanoma cells
13. FLT4 receptor tyrosine kinase contains seven immunoglobulin-like loops and is expressed in multiple human tissues and cell lines
14. Vascular endothelial growth factors VEGF-B and VEGF-C are expressed in human tumors
15. Hyperplasia of lymphatic vessels in VEGF-C transgenic mice
16. VEGF and VEGF-C: Specific induction of angiogenesis and lymphangiogenesis in the differentiated avian chorioallantoic membrane
17. Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development
18. VEGF-C receptor binding and pattern of expression with VEGFR-3 suggests a role in lymphatic vascular development
19. Regulation of the steps of angiogenesis by human head and neck squamous cell carcinomas
20. Heparin-binding growth factor(s) derived from head and neck squamous cell carcinomas induce endothelial cell proliferations
21. Vascular endothelial growth factor expression in head and neck squamous cell carcinoma
22. Vascular endothelial growth factor in squamous cell head and neck carcinoma: Expression and prognostic significance
23. Expression of vascular endothelial growth factor in human oral squamous cell carcinoma: Its association with tumour progression and p53 gene status
24. Role of angiogenic factors: Coexpression of interleukin-8 and vascular endothelial growth factor in patients with head and neck squamous carcinoma
25. Vascular endothelial growth factor is a marker of tumor invasion and metastasis in squamous cell carcinomas of the head and neck
26. Prognostic significance of vascular endothelial growth factor protein levels in oral and oropharyngeal squamous cell carcinoma
27. Differential modulation of proliferation, matrix metalloproteinase expression and invasion of human head and neck squamous carcinoma cells by c-erbB ligands
28. Epidermal growth factor-like ligands differentially up-regulate matrix metalloproteinase-9 in head and neck squamous carcinoma cells
29. Vascular endothelial growth factor family members are differentially regulated by c-erb B signaling in head and neck squamous carcinoma cells
30. Over-expression of epidermal growth factor receptor in human head and neck squamous carcinoma cell lines correlates with matrix metalloproteinase-9 expression and in vitro invasion
31. Expression and regulation of c-erb B ligands in human head and neck squamous carcinoma cells
32. Mode of invasion: Bleomycin sensitivity and clinical course in squamous cell carcinoma of the oral cavity
33. Proteolytic processing regulates receptor specificity and activity of VEGF-C
34. Biosynthesis of vascular endothelial growth factor-D involves proteolytic processing which generates non-covalent homodimers
35. Role of vascular endothelial growth factor C expression in the development of lymph node metastasis in gastric cancer
36. Vascular endothelial growth factors VEGF-B and VEGF-C
37. Extracellular cleavage of the vascular endothelial growth factor 189-amino acid form by urokinase is required for its mitogenic effect
38. Expression of vascular permeability factor/vascular endothelial growth factor in human hepatocellular carcinoma
39. Expression of the angiogenic factors vascular endothelial cell growth factor, acidic and basic fibroblast growth factor, tumor growth factor beta-1, platelet-derived endothelial cell growth factor, placenta growth factor, and pleiotrophin in human primary breast cancer and its relation to angiogenesis
40. Vascular endothelial growth factor (VEGF) mRNA isoform expression pattern is correlated with liver metastasis and poor prognosis in colon cancer
41. VEGF, VEGF-B, VEGF-C, and their receptors KDR, FLT-1 and FLT-4 during the neoplastic progression of human colonic mucosa
42. Expression of vascular endothelial growth factors A, B, C, and D and their relationships to lymph node status in lung adenocarcinoma
43. Prognostic value of vascular endothelial growth factor expression in gastric carcinoma
44. Vascular endothelial growth factor expression predicts outcome and lymph node metastasis in squamous cell carcinoma of the esophagus
45. Vascular endothelial growth factor expression and angiogenesis in non-small cell lung carcinomas
46. Vascular endothelial growth factor-C expression in human prostatic carcinoma and its relationship to lymph node metastasis
47. VEGFR-3 and its ligand VEGF-C are associated with angiogenesis in breast cancer
48. Stimulation of endothelial cell migration by vascular permeability factor/vascular endothelial growth factor through cooperative mechanisms involving the alphaVbeta3 integrin, osteopontin, and thrombin
49. Vascular endothelial growth factor induces heparin-binding epidermal growth factor-like growth factor in vascular endothelial cells
50. Vascular endothelial growth factor (VEGF)-C synergizes with basic fibroblast growth factor and VEGF in the induction of angiogenesis in vitro and alters endothelial cell extracellular proteolytic activity
51. Reciprocal paracrine interactions between tumour cells and endothelial cells: The 'angiogenesis progression' hypothesis
52. Markedly increased amounts of messenger RNAs for vascular endothelial growth factor and placenta growth factor in renal cell carcinoma associated with angiogenesis
53. Expression of vascular endothelial growth factor, its receptor, and other angiogenic factors in human breast cancer